Back To Top
Experience the Future of Intelligent Investing Today
Neural Trade. One AI system. 1000s of real-time data points. Instant market intelligence.
State-of-the-art data science and AI power quant models, valuation, sentiment, and volatility analysis. Serious tools built for serious decisions.
Identify better entry and exit zones using real-time price patterns, sentiment, and statistical confidence.
No posts were found for provided query parameters.
No posts were found for provided query parameters.
Bitcoin has surged past $81,000, marking a new record high fueled by what some analysts are calling a “Trump Rally.” This price spike aligns with
BofA Securities analysts adjusted their price target for Omnicell (NASDAQ:OMCL) from $57 to $54, maintaining a Neutral rating on the stock. This revision follows insights
UBS analysts raised the rating for MeridianLink (NYSE:MLNK) from Sell to Neutral, adjusting their price target from $18.00 to $25.50. This upgrade reflects improved performance
BMO Capital analysts downgraded Celanese (NYSE:CE) from Market Perform to Underperform, lowering their price target on the stock from $138.00 to $76.00. This shift came
Guggenheim analysts downgraded Smartsheet (NYSE:SMAR) from Buy to Neutral following the expiration of the “go-shop” period related to its proposed acquisition by Blackstone and Vista
UBS analysts lowered their rating on Vale S.A. (NYSE:VALE) from Buy to Neutral and reduced the stock’s price target from $14.00 to $11.50. Despite Vale’s
JMP Securities analysts shifted their outlook on agilon health (NYSE:AGL), downgrading the company’s rating from Market Outperform to Market Perform. This adjustment followed agilon’s release
AUD/USD snapped a 5-week losing streak with a marginal 0.3% gain. But it was the most volatile week since April thanks to the US election,